Pharmalittle: Bayer offered funding to influence foreign press group
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is once again rather modest. We hope to hang with one or more short people, catch up on our reading, and take a constitutional walk or two. And what about you? There is a holiday looming on this side of the pond, so this may be an opportunity to plan a menu or an invitation list, the hazards of family gatherings notwithstanding. Alternatively, you could ignore the hullabaloo and plot an escape to somewhere faraway. Or you can simply take stock and enjoy the respite. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.
Bayer (BAYRY) communications executives discussed plans to give the drug maker influence within a prestigious American not-for-profit dedicated to media freedoms that would protect and promote the company’s business interests in exchange for generous funding, The Guardian reveals. Emails indicated the company sought a voice in several initiatives of the Foreign Press Association and its related foundation with a goal of “adding value to Bayer and the FPA.” And Bayer was to be “actively informed and involved in the supervision of these planned initiatives.”